Search alternatives:
improvement decrease » improvements increased (Expand Search), improvement success (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
Showing 1 - 20 results of 8,259 for search '(( significant improvement decrease ) OR ( significant ((side decrease) OR (mean decrease)) ))', query time: 0.42s Refine Results
  1. 1
    Summary of significant treatment × time effect.

    Summary of significant treatment × time effect. by Wensheng Xiao (16557866)

    Published 2024
    Save to List
    Saved in:
  2. 2
    Summary of significant single-arm time effect.

    Summary of significant single-arm time effect. by Wensheng Xiao (16557866)

    Published 2024
    Save to List
    Saved in:
  3. 3
    The mean and standard deviation of parameters.

    The mean and standard deviation of parameters. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 4
    Lymphocytes decreased in mouse pneumonia model.

    Lymphocytes decreased in mouse pneumonia model. by Qi Xu (134661)

    Published 2025
    Save to List
    Saved in:
  5. 5
    Stability differences between condition 1 and other conditions across participants on the non-hemiparetic side (NHP) side.

    Stability differences between condition 1 and other conditions across participants on the non-hemiparetic side (NHP) side. by Hyung Suk Yang (20442438)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 6
    Mean case duration before and after intervention (t-statistic = -3.35, p <i>< </i>0.001), indicating a statistically significant difference in means.

    Mean case duration before and after intervention (t-statistic = -3.35, p <i>< </i>0.001), indicating a statistically significant difference in means. by Mohammad Bakhtiari (11838264)

    Published 2025
    Save to List
    Saved in:
  7. 7
    Average stability values (mean ± standard deviation) and statistical results.

    Average stability values (mean ± standard deviation) and statistical results. by Hyung Suk Yang (20442438)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 8
    Average mean decrease Gini across 100 partitions for the top 10 most important variables for binary mixed model and random forest.

    Average mean decrease Gini across 100 partitions for the top 10 most important variables for binary mixed model and random forest. by Helal El-Zaatari (20442243)

    Published 2025
    Save to List
    Saved in:
  9. 9
    Stability differences between condition 1 and other conditions across participants on the hemiparetic (HP) side.

    Stability differences between condition 1 and other conditions across participants on the hemiparetic (HP) side. by Hyung Suk Yang (20442438)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 10
    miRNA 221 improved left ventricular contractile function in MIRI mice.

    miRNA 221 improved left ventricular contractile function in MIRI mice. by Hongyu Li (1332669)

    Published 2025
    Save to List
    Saved in:
  11. 11
    Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size.

    Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size. by Francesca Catto (21253435)

    Published 2025
    Save to List
    Saved in:
  12. 12
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 13
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 14
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 16
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 17
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 19
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 20
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: